key: cord-0031200-swz85ym7
authors: Gesesew, Hailay Abrha; Mwanri, Lillian; Woldemichael, Kifle; Ward, Paul
title: Editorial: Stigma and HIV Care in Low- and Middle-Income Countries (LMICs)
date: 2022-04-27
journal: Front Public Health
DOI: 10.3389/fpubh.2022.900590
sha: cd69720157c1640086e978192ef62c3ec1698197
doc_id: 31200
cord_uid: swz85ym7

nan

Human immunodeficiency virus (HIV)-related stigma is a global public health issue and substantially affects low-and middle-income countries (LMICs) which are known to be the hardest hit by HIV. Despite HIV testing services and HIV treatment (antiretroviral therapy, ART) being freely available in several LMICs, HIV testing coverage is very low, early access to ART is low, and retention in care is not satisfactory. Stigma is a cross-cutting barrier to the entire HIV care continuum, which includes the following: HIV testing and counseling, access to HIV treatment, treatment adherence, retention, and virological suppression. As such, HIV-related stigma contributes to negative HIV care and treatment outcomes such as delayed HIV diagnosis, delayed HIV treatment access, poor adherence, clinical, immunological, and virological failure, and subsequently attrition. In relation to this, in 2014, UNAIDS proposed an ambitious goal called UNAIDS 90-90-90 where respectively it was expected that 90% of individuals would know their HIV status, would receive sustained ART, and through ART would have viral suppression. The goal was planned to be achieved by 2020, however, several LMICs are yet to achieve this target by far. Stigma has been consistently named as a cross-cutting factor. As such, contextual studies are needed to explore the link between stigma and HIV care and possible strategies to halt stigma. As part of this exploration, between 1 January 2021 and 31 January 2022, a special topic entitled "Stigma and HIV Care in Low-and Middle-Income Countries (LMICs)" was opened and a dedicated team of scholars handled the editorial work and acted as guest editors to facilitate the timely peer-review and publication of relevant manuscripts from multiple studies (1).

A total of six manuscripts were submitted of which two were rejected and four were published. The published papers included qualitative studies from Zimbabwe and Indonesia, a mixed methods study from Ghana, and a scoping review of studies in LMICs. By February 2022, the special topic achieved over 9,300 views. As an example of the broadness of the subject covered, Kanyemba et al. Because the emergence of the COVID-19 pandemic took the attention of research in 2020/21, fewer than expected abstracts were submitted to this stigma-related special issue despite stigma's multipronged impacts and it being a cross-cutting barrier to the entire HIV care continuum. Nevertheless, these published articles covered different age and population groups, methodologies, countries, and perspectives. It is also important to note that this special topic reflects the continued investment of the research community, the supporting editorial team, and the Frontiers in Public Health publishing staff to facilitate the publication process in times of crisis.

HAG drafted the manuscript. All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.

Special Topic 'Stigma and HIV Care in Low-and Middle-Income Countries (LMICs)'. Available online at

The authors would like to express their gratitude to the reviewers and scientists who contributed to this crucial topic. Special thanks to Frontiers in Public Health for offering this special issue, and to the staff of the Frontiers publishing department, particularly to Ms. Aimee Lee for her continuous and unmitigated support.

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Publisher's Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.Copyright © 2022 Gesesew, Mwanri, Woldemichael and Ward. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.